Neurological events during treatment with vitamin K antagonists versus direct oral anticoagulants for left ventricular thrombus: Safety and efficacy association

Key Points

• Neurological events were notably observed in patients treated with vitamin K antagonists compared to direct oral anticoagulants.
• Findings indicated a higher incidence of 14% adverse neurological events among those receiving vitamin K antagonists.
• Assessment involved comparing the safety profiles between vitamin K antagonists and direct oral anticoagulants in managing left ventricular thrombus.
• Results highlight a concern for increased risk in patients treated with vitamin K antagonists, suggesting caution in clinical applications.